PubRank

C W Potter

Author PubWeight™ 160.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Determinants of immunity to influenza infection in man. Br Med Bull 1979 4.62
2 Immunity to influenza in ferrets. I. Response to live and killed virus. Br J Exp Pathol 1972 2.78
3 Incidence of herpes simplex virus types 1 and 2 isolated in patients with herpes genitalis in Sheffield. Br J Vener Dis 1982 2.48
4 Declining T-cell immunity to influenza, 1977-82. Lancet 1983 2.34
5 Simian virus 40-induced T and tumor antigens. J Virol 1969 1.76
6 Immunity to influenza in ferrets. II. Influence of adjuvants on immunization. Br J Exp Pathol 1972 1.70
7 A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group. J Hyg (Lond) 1975 1.67
8 The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection. J Hyg (Lond) 1979 1.65
9 The nPCR detection of Chlamydia pneumoniae and Chlamydia trachomatis in children hospitalized for bronchiolitis. J Infect 1996 1.62
10 Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines. J Hyg (Lond) 1977 1.62
11 Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis. J Hyg (Lond) 1984 1.49
12 Therapeutic effect of 1-adamantanamine hydrochloride in naturally occurring influenza A 2 -Hong Kong infection. A controlled double-blind study. Lancet 1971 1.49
13 Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccine in unprimed children. Report to the Medical Research Council Committee on influenza and other respiratory virus vaccines. J Biol Stand 1980 1.48
14 Genetic differentiation between parapatric 'nearshore' and 'offshore' populations of the bottlenose dolphin. Proc Biol Sci 1998 1.47
15 Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. J Biol Stand 1979 1.45
16 Immunity to influenza in ferrets. VII. Effect of previous infection with heterotypic and heterologous influenza viruses on the response of ferrets to inactivated influenza virus vaccines. J Hyg (Lond) 1974 1.40
17 Changes in the antibody status of a population following epidemic infection by influenza virus A2-Hong Kong-1-68. J Hyg (Lond) 1970 1.37
18 Reactogenicity and immunogenicity of whole and ether-Tween-split influenza A virus vaccines in volunteers. J Infect Dis 1978 1.33
19 HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines. Lancet 1981 1.28
20 Cytogenetic findings in six posterior uveal melanomas: involvement of chromosomes 3, 6, and 8. Genes Chromosomes Cancer 1990 1.28
21 Efficacy of topical acyclovir cream in first and recurrent episodes of genital herpes. Antiviral Res 1983 1.26
22 Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine. J Infect Dis 1977 1.25
23 Observations on the A2 England influenza epidemic: a clinicopathological study. Am Heart J 1976 1.24
24 HI antibody to various influenza viruses and adenoviruses in individuals of blood groups A and O. J Hyg (Lond) 1969 1.24
25 In vivo selection of an influenza A2 strain resistant to amantadine. Nature 1970 1.24
26 Anatomical evidence for a countercurrent heat exchanger associated with dolphin testes. Anat Rec 1992 1.22
27 Association of HSV-1 with cervical infection. Lancet 1981 1.20
28 Potentiation of the antibody response to inactivated A2-Hong Kong vaccines by previous heterotypic influenza virus infection. Microbios 1974 1.18
29 The incidence of HI antibody to Influenza virus A2/Singapore/ 1/57 in individuals of blood groups A and O. J Immunol 1967 1.13
30 Responses of volunteers to inactivated influenza virus vaccines. J Hyg (Lond) 1981 1.12
31 Immunity to influenza in ferrets. V. Immunization with inactivated virus in adjuvant 65. J Hyg (Lond) 1973 1.08
32 Immunity to influenza in ferrets. XI. Cross-immunity between A/Hong Kong/68 and A/England/72 viruses: serum antibodies produced by infection or immunization. J Hyg (Lond) 1974 1.07
33 Comparison of transformation and T antigen induction in human cell lines. J Virol 1970 1.07
34 A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity. J Hyg (Lond) 1983 1.07
35 A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity. J Hyg (Lond) 1983 1.06
36 Cellular immunity to myelin basic protein in man and in animal model systems as measured by the macrophage migration inhibition test. Br J Cancer 1975 1.06
37 Specific tumour antigen induced by chick embryo lethal orphan (CELO) virus. J Gen Virol 1969 1.06
38 Immunity to influenza in ferrets. IV. Antibody in nasal secretions. J Infect Dis 1972 1.05
39 Non-random abnormalities of chromosomes 3, 6, and 8 associated with posterior uveal melanoma. Genes Chromosomes Cancer 1992 1.05
40 A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection. J Hyg (Lond) 1983 1.03
41 Acyclovir prophylaxis of recurrent genital herpes: randomised placebo controlled crossover study. Genitourin Med 1985 1.02
42 Antibody response of hamsters to A2-Hong Kong virus vaccine after priming by heterotypic virus infection. Infect Immun 1973 1.02
43 Transmissibility of influenza viruses in hamsters. Arch Virol 1982 1.02
44 Immunity to challenge in volunteers vaccinated with an inactivated current or earlier strain of influenza A(H3N2). J Hyg (Lond) 1978 1.01
45 Amantadine resistance in clinical influenza A (H3N2) and (H1N1) virus isolates. J Antimicrob Chemother 1986 1.01
46 Antiviral, immunosuppressive and antitumour effects of ribavirin. Nature 1976 1.01
47 Effect of preinfection and preimmunization on the serum antibody response to subsequent immunization with heterotypic influenza vaccines. J Immunol 1974 1.00
48 Humoral and secretory antibody responses to immunization with low and high dosage split influenza virus vaccine. Arch Virol 1975 0.99
49 Immune response to adenovirus 12-induced tumour antigens, as measured in vitro by the macrophage migration inhibition test. Eur J Cancer 1973 0.99
50 The hamster as a model system for the study of influenza vaccines. Postgrad Med J 1976 0.99
51 Levamisole inactive in treatment of four animal tumours. Nature 1974 0.99
52 Immunity following intranasal administration of an inactivated, freeze-dried A/England/42/72 vaccine. Arch Virol 1975 0.98
53 The use of the single radial haemolysis test for assessing antibody response and protective antibody levels in an influenza B vaccine study. J Biol Stand 1983 0.98
54 The relationship between interferon and virus virulence in influenza virus infections of the mouse. J Med Microbiol 1973 0.98
55 Immunity to influenza in ferrets. XIV: Comparative immunity following infection or immunization with live or inactivated vaccine. Br J Exp Pathol 1981 0.98
56 Influenza virus infection of the guinea pig: immune response and resistance. Med Microbiol Immunol 1979 0.97
57 The association of adenovirus infection with disease of the intestinal tract. Mod Trends Med Virol 1967 0.97
58 Loss of polymorphic A and B locus HLA antigens in colon carcinoma. Br J Cancer 1988 0.97
59 Influenza virus infection of a newborn rats: virulence of recombinant strains prepared from a cold-adapted, attenuated parent. Arch Virol 1979 0.96
60 Immunity to influenza in ferrets. VI. Immunization with adjuvanted vaccines. Arch Gesamte Virusforsch 1973 0.94
61 Immunological relationships of some oncogenic DNA viruses. I. Transplantation immunity studies. Arch Gesamte Virusforsch 1969 0.94
62 A contribution of cellular immunity to protection against influenza in man. Med Microbiol Immunol 1978 0.93
63 Enhanced response to influenza A vaccines in hamsters primed by prior heterotype influenza infection. Arch Gesamte Virusforsch 1973 0.93
64 Immunity to influenza in ferrets. 8. Serological response of ferrets to influenza virus vaccines after infection with heterotypic strains of influenza. Med Microbiol Immunol 1973 0.93
65 A new, surface-antigen-adsorbed influenza virus vaccine. I. Studies on immunogenicity in hamsters. J Hyg (Lond) 1975 0.92
66 Detection of Chlamydia trachomatis by the polymerase chain reaction in young patients with acute epididymitis. Eur J Clin Microbiol Infect Dis 1992 0.91
67 The therapeutic effect of amantadine in influenza occurring during the winter of 1971-2 assessed by double-blind study. J R Coll Gen Pract 1973 0.90
68 Immune response in volunteers to intranasal inoculation with freeze-dried influenza Q/Hong Kong/68 vaccine. J Biol Stand 1975 0.90
69 Inactivated influenza virus vaccines in man: a comparative study of subunit and split vaccines using two methods for assessment of antibody responses. Vaccine 1984 0.90
70 Transformation of human cells by SV40 virus. Br J Cancer 1975 0.90
71 In vivo and in vitro hamster models in the assessment of virulence of recombinant influenza viruses. Antiviral Res 1983 0.90
72 Reactogenicity and immunogenicity of a surface-antigen-adsorbed influenza virus vaccine in children. J Clin Pathol 1979 0.89
73 The use of microbiology in the study of hygiene behaviour. Microbios 1996 0.89
74 Aminoadamantane-resistant strains of influenza A2 virus. J Hyg (Lond) 1973 0.89
75 An immunologic marker technique for the Cendehill vaccine strain of rubella virus. J Immunol 1970 0.88
76 Cellular immunity to encephalitogenic factor in man as measured by the macrophage migration inhibition test: the effects of serum. Br J Cancer 1978 0.87
77 The specificity of cellular immune reactions to three DNA virus induced tumours, as measured by the macrophage migration inhibition test. Eur J Cancer 1975 0.87
78 Antibody response to inactivated influenza vaccine given by different routes in patients with chronic bronchopulmonary disease. Thorax 1973 0.87
79 Chromosome studies in eleven colorectal tumors. Cancer Genet Cytogenet 1990 0.87
80 A reverse transcriptase-PCR based assay for in-vitro antibiotic susceptibility testing of Chlamydia pneumoniae. J Antimicrob Chemother 1996 0.86
81 The replication of type A influenza viruses in the infant rat: a marker for virus attenuation. J Gen Virol 1980 0.86
82 Transplantation immunity following immunization with extracts of adenovirus 12 tumour cells. Int J Cancer 1970 0.86
83 Immunity to influenza in ferrets. X. Intranasal immunization of ferrets with inactivated influenza A virus vaccines. Infect Immun 1974 0.86
84 Immunity to influenza in ferrets. 13. Protection against influenza infection by serum antibody to homologous haemagglutinin or neuraminidase antigens. Med Microbiol Immunol 1974 0.86
85 Immune response of human volunteers and animals to vaccination with egg-grown influenza A (H1N1) virus is influenced by three amino acid substitutions in the haemagglutinin molecule. Vaccine 1993 0.85
86 Immunity to influenza in ferrets. XII. Immunization of ferrets with TNBP-split influenza virus vaccine. Arch Gesamte Virusforsch 1974 0.85
87 Immunity to influenza in ferrets. 3. Proteins in nasal secretions. J Infect Dis 1972 0.85
88 Efficacy of combined treatment with oral and topical acyclovir in first episode genital herpes. Genitourin Med 1986 0.84
89 The effects of peroral or local aerosol administration of 1-aminoadamantane hydrochloride (amantadine hydrochloride) on influenza infections of the ferret. J Antimicrob Chemother 1977 0.84
90 Tumorgenicity of herpesvirus hominis type 2-transformed cells (line 333-8-9) in adult hamsters. J Pathol 1979 0.84
91 Suppression of natural and activated human antitumour cytotoxicity by human seminal plasma. Clin Exp Immunol 1986 0.84
92 Cellular immunity to encephalitogenic factor as measured by macrophage migration inhibition during tumour induction and growth. Br J Cancer 1978 0.84
93 Immune response and protection against influenza A infection in mice immunised with subunit influenza A vaccine in combination with whole cell or acellular DTP vaccine. Vaccine 1995 0.83
94 Properties of transplantation antigen present in cell-free extracts of adenovirus-12 tumours. Eur J Cancer 1972 0.83
95 Assessment of resistance to influenza virus infection in animal models. Dev Biol Stand 1975 0.83
96 Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice. Vaccine 1993 0.83
97 Growth of influenza A viruses in hamsters. Arch Virol 1980 0.83
98 Depressed spontaneous natural killing and interferon augmentation in patients with malignant lymphoma. Eur J Cancer Clin Oncol 1982 0.83
99 Inactivation of influenza and other viruses by a mixture of virucidal compounds. Appl Microbiol 1971 0.83
100 Antibody response and persistence in volunteers following immunization with varying dosages of a trivalent surface antigen influenza virus vaccine. J Hyg (Lond) 1985 0.83
101 Some aspects of the role of viruses in cancer. Postgrad Med J 1979 0.83
102 Induction of IL-2 and IFN-gamma in BALB/c mice immunised with subunit influenza A vaccine in combination with whole cell or acellular DTP vaccine. J Med Microbiol 1997 0.82
103 Differential response of ferrets to infection with virulent and avirulent influenza viruses: a possible marker of virus attenuation. Arch Virol 1977 0.82
104 The hamster as an experimental animal for the study of influenza. I. The role of antibody in protection. Med Microbiol Immunol 1976 0.82
105 Immunity to influenza in ferrets. IX. Delayed hypersensitivity following infection or immunization with A2/Hong Kong virus. Microbios 1975 0.82
106 Chick embryo lethal orphan (CELO) virus as a possible contaminant of egg-grown virus vaccines. J Hyg (Lond) 1969 0.82
107 The serological response of experimental animals to inactivated whole and split influenza virus vaccines. J Biol Stand 1977 0.81
108 Immunity to influenza virus infection induced by heterologous, inactivated vaccines. Med Microbiol Immunol 1978 0.81
109 Infant rat model of attenuation for recombinant influenza viruses prepared from cold-adapted attenuated A/Ann Arbor/6/60. Infect Immun 1982 0.80
110 IgG subclass response and protection against challenge following immunisation of mice with various influenza A vaccines. J Med Microbiol 1994 0.80
111 Influenza virus infection in newborn rats: a possible marker of attenuation for man. J Med Virol 1978 0.80
112 Zwitterionic detergent solubilisation of HSV-1 surface antigens. Arch Virol 1988 0.80
113 Immunological cross-reactivity between acid extracts of myelin, liver and neoplastic tissues: studies in immunized guinea-pigs. Br J Cancer 1979 0.80
114 In vivo studies of cell-mediated and humoral immune responses to adenovirus 12-induced tumour cells. Arch Gesamte Virusforsch 1973 0.79
115 The infant rat as a model for assessment of the attenuation of human influenza viruses. J Med Microbiol 1979 0.79
116 The spread and persistence of influenza viruses in normal and cyclophosphamide-treated mice. J Med Virol 1981 0.78
117 A comparative study of the reactogenicity and immunogenicity of two inactivated influenza vaccines in children. J Biol Stand 1982 0.78
118 Cold-adapted reassortants of influenza A virus: pathogenicity of A/Ann Arbor/6/60 X A/Alaska/6/77 reassortant viruses in vivo and in vitro. Arch Virol 1986 0.78
119 Modulation of type IV collagenase and plasminogen activator in a hamster fibrosarcoma by basement membrane components and lung fibroblasts. Br J Cancer 1988 0.78
120 Antigenicity in hamsters of inactivated vaccines prepared from recombinant influenza viruses. J Hyg (Lond) 1981 0.78
121 Use of the enzyme-linked immunosorbent assay (ELISA) for the estimation of serum antibodies in an influenza virus vaccine study. Med Microbiol Immunol 1981 0.78
122 Factors influencing the establishment of tumour-infiltrating lymphocyte cultures from human breast carcinoma and colon carcinoma tissue. Eur J Cancer 1991 0.78
123 Influenza virus infection of newborn rats: virulence of recombinant strains prepared from influenza virus strain A/Okuda/57. J Med Microbiol 1980 0.78
124 Herpes simplex virus type-specific antibodies detected by indirect and competition ELISA. Comparison of sera from patients with carcinoma of the uterine cervix, age matched controls and patients with recurrent genital herpes. Acta Pathol Microbiol Immunol Scand B 1983 0.78
125 Infectivity and reactogenicity of reassortant cold-adapted influenza A/Korea/1/82 vaccines obtained from the USA and USSR. Bull World Health Organ 1987 0.78
126 Reactogenicity and immunogenicity of three inactivated influenza virus vaccines in children. J Biol Stand 1981 0.78
127 Properties of a Herpes virus-transformed hamster cell line--I. Growth and culture characteristics of sublines of high and low metastatic potential. Eur J Cancer Clin Oncol 1982 0.78
128 Use of zwitterionic detergent for the preparation of an influenza virus vaccine. 1: Preparation and characterization of disrupted virions. Vaccine 1984 0.78
129 A comparison of adenovirus 12 induced T and tumour antigens by rate-zonal centrifugation. J Gen Virol 1970 0.78
130 The antibody response and immunity to challenge infection induced by whole, inactivated and tween-ether split influenza vaccines. Dev Biol Stand 1978 0.78
131 Corynebacterium parvum stimulation of adherent and non-adherent cytotoxic cells in mice. Br J Cancer 1981 0.78
132 Incidence of Chlamydia antibody in patient groups, as measured by the ELISA technique. Int J STD AIDS 1990 0.77
133 Surgical wound dressings as barriers to an enveloped virus. J Hosp Infect 1990 0.77
134 Sequential genital infections with herpes simplex virus types 1 and 2. Genitourin Med 1989 0.77
135 Production of plasminogen activator by a primary HSV-2-induced hamster fibrosarcoma and its in vivo derived sublines. Cancer 1986 0.77
136 Inhibition of tumour formation with adenovirus 12 tumour cells in hamsters immunized with various adenoviruses. Nature 1967 0.77
137 Persistent rubella virus infection in laboratory animals. Arch Gesamte Virusforsch 1971 0.77
138 Cell-mediated immunity to encephalitogenic factor (MMI test) in women with cervical dysplasia and carcinoma in situ: the effects of serum. Br J Cancer 1978 0.77
139 Demonstration of an immunosuppressive action of detergent-disrupted influenza virus on the antibody response to inactivated whole virus vaccine. J Gen Virol 1987 0.77
140 Use of single radial haemolysis for assessing antibody response to influenza virus vaccines in animals. Med Microbiol Immunol 1987 0.77
141 The hamster as an experimental animal for the study of influenza. II. The role of spleen cells in protection. Med Microbiol Immunol 1976 0.77
142 Reduced susceptibility to natural killer cell lysis of hamster tumours exhibiting high levels of spontaneous metastasis. Cancer Lett 1983 0.77
143 Dose-response activity of ribavirin against influenza virus infection in ferrets. J Antimicrob Chemother 1977 0.77
144 Therapy of spontaneously metastatic HSV-2 induced hamster tumours with cortisone acetate administered with or without heparin. Eur J Cancer Clin Oncol 1987 0.77
145 Properties of a herpesvirus-transformed hamster cell line: immunogenicity of sublines of high and low metastatic potential. Int J Cancer 1984 0.77
146 Interference following dual inoculation with influenza A (H3N2) and (H1N1) viruses in ferrets and volunteers. J Med Virol 1983 0.76
147 Biochemical characterization of herpes simplex virus type-1-immunostimulating complexes (ISCMOs): a multi-glycoprotein structure. Vaccine 1991 0.76
148 Comparative antibody responses and protection in mice immunised by oral or parenteral routes with influenza virus subunit antigens in aqueous form or incorporated into ISCOMs. J Med Microbiol 1995 0.76
149 Susceptibility of HSV strains from patients with genital herpes treated with various formulations of acyclovir. J Antimicrob Chemother 1986 0.76
150 Chick embryo lethal orphan (CELO) virus: some physical and immunological properties. Virology 1971 0.76
151 In vivo tumour x host cell fusion in spontaneous Syrian hamster metastasis. Eur J Cancer Clin Oncol 1989 0.76
152 Comparative studies of transformed hamster cells by Herpesvirus hominis types 1 and 2. Br J Exp Pathol 1982 0.75
153 Antibody to Herpesvirus hominis in patients with carcinoma of the cervix. Br J Exp Pathol 1982 0.75
154 Detection of natural cytotoxicity in Syrian hamsters. Br J Cancer 1980 0.75
155 Failure to induce transplantation immunity to an SV40-induced tumour in hamsters immunized with basic proteins of myelin or malignant tissues. Br J Cancer 1978 0.75
156 The effect of bacterial peptidoglycans on the immune response of hamsters to influenza virus vaccines. Clin Exp Immunol 1982 0.75
157 Efficacy of oral treatment with acyclovir and co-trimoxazole in first episode genital herpes. Genitourin Med 1986 0.75
158 Specific enhancement of transplantation immunity with heat-killed Mycobacterium butyricum and immunizing extracts from adenovirus 12-induced tumour cells. Br J Cancer 1972 0.75
159 The hamster as a model for the study of immunity to influenza virus infection. Fed Proc 1978 0.75
160 Studies with live attenuated influenza virus in chronic bronchitis. Thorax 1977 0.75
161 Changes accompanying long term tissue culture of an adenovirus type 12 tumour cell line. Br J Cancer 1968 0.75
162 The effects of 1-beta-D ribofuranosyl-1, 2, 4-triazole-3-carboxamide (Ribavirin) on the transplanted tumours of animals. Eur J Cancer 1977 0.75
163 The subclass IgG responses of mice to influenza surface proteins formulated into liposomes. Antiviral Res 1993 0.75
164 The antiviral activity of amantadine and poly (C,S4U) on influenza virus infection of infant rats. J Antimicrob Chemother 1981 0.75
165 The amantadine-sensitivity of recombinant and parental influenza virus strains. Med Microbiol Immunol 1981 0.75
166 Some properties of adenovirus 12-induced transplantation antigen, as measured by the macrophage migration inhibition test. Eur J Cancer 1975 0.75
167 The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus. Arch Virol 1992 0.75
168 Isolation and characterisation of two strains of Herpesvirus hominis type 1 from fallopian tubes. J Med Microbiol 1982 0.75
169 Studies on the antitumour effects of N-137. Chemotherapy 1982 0.75
170 Demonstration of a tumour and transplantation antigen in hamster tumours induced by an avian adenovirus (CELO). Arch Gesamte Virusforsch 1970 0.75
171 A comparison of the sensitivity of cell cultures to diphtheria toxin by the dye-uptake method. J Med Microbiol 1971 0.75
172 Subpopulations of colon cancer cells survive freezing. In Vitro Cell Dev Biol 1991 0.75
173 Antiviral activity of ribavirin on influenza infection in ferrets. J Antimicrob Chemother 1975 0.75
174 Studies on the high- and low-affinity rosette-forming T-lymphocytes in patients with Hodgkin's and non-Hodgkin's lymphoma. Eur J Cancer 1981 0.75
175 Immunological relationships of some oncogenic DNA viruses. II. Primary tumour inhibition studies. Arch Gesamte Virusforsch 1969 0.75
176 Detection and characterization of natural killer cells in Syrian golden hamsters. Eur J Cancer Clin Oncol 1983 0.75
177 Effect of immunisation with heat-killed micro-organisms on transplantation immunity to adenovirus-12-induced tumour cells. J Med Microbiol 1974 0.75
178 Recurrences after first episodes of genital herpes in patients treated with topical acyclovir cream. Antiviral Res 1984 0.75
179 Latent HSV-1 infection in mice immunized with a zwitterionic detergent-extracted HSV-1 antigen preparation. Arch Virol 1989 0.75
180 Immunofluorescence studies of T and virus capsid antigens induced by chick embryo lethal orphan virus. J Gen Virol 1970 0.75
181 Characterization and immunogenicity of HSV-1 antigens obtained following zwitterionic detergent treatment. Vaccine 1986 0.75
182 Natural killer cell activity and response to phytohaemagglutinin compared with the histological diagnosis of patients with transitional cell carcinoma of the bladder. Br J Urol 1982 0.75
183 Reassortants of influenza B viruses for use in vaccines: an evaluation. Arch Virol 1985 0.75
184 Altered natural killer cell response in patients with malignant lymphoma. Philos Trans R Soc Lond B Biol Sci 1982 0.75
185 Chromosome, transplantation and tumour antigen studies of three virus-induced tumour cell lines. Arch Gesamte Virusforsch 1971 0.75
186 Proceedings: Antibody response of hamsters to influenza vaccine following heterologous virus infection. J Med Microbiol 1973 0.75
187 Effect of ethidium bromide on transplanted virus-induced tumor cells. J Natl Cancer Inst 1976 0.75
188 Antibody levels in human sera to oncogenic adenoviruses (types 7, 12 and 18). Arch Gesamte Virusforsch 1966 0.75
189 Antibody responses and protection in mice immunized with herpes simplex virus type 1 antigen immune-stimulating complex preparations. J Gen Virol 1989 0.75
190 Non-random chromosome changes in a herpes-virus-transformed Syrian hamster cell line and its metastatic derivatives. Int J Cancer 1984 0.75
191 Immunogenicity of influenza and HSV-1 mixed antigen ISCOMs in mice. Arch Virol 1995 0.75
192 Enhanced transformation of hamster embryo fibroblasts by SA7 following pre-treatment with various chemicals. Eur J Cancer 1980 0.75
193 In-vitro inhibition of influenza virus A-Mill Hill 1-72 by amantadine. Lancet 1973 0.75
194 Use of a zwitterionic detergent for the preparation of an influenza virus vaccine: 2. Immunogenicity of Empigen-treated virus in animals. Vaccine 1984 0.75
195 The lymphoreticular response to a transplanted adenovirus 12-induced tumour of CBA mice. J Pathol 1976 0.75
196 The identification of informative parameters in the flow cytometric analysis of breast carcinoma. Eur J Cancer 1993 0.75